STUDY OF EXPERIMENTAL ULCERATIVE COLITIS INDUCED BY CARRAGEENAN IN RABBIT
スポンサーリンク
概要
- 論文の詳細を見る
We made lesions which resembled those of ulcerative colitis in rabbits and tried to clarify pathogenesis of the disease by studying the lesional tissues at the large intestine histologically together with immunological approach.Rabbits with an average body weight of 2kg were chosen as objects of the study. They were sensitized with 1% physiological saline including λ-degraded-carrangeenan. After 1 week, 0.5% water solution including λ-degraded-carrageenan was given them as drinking water for about 6 weeks.Diarrhea and loss of body weight were seen in the 2nd week of the start of the trial, and bloody stool was observed in 80% of them in the 6th week. Endoscopically, edema was observed in the 2nd week and disseminated erosion and ulcer (ul II) were found in various parts of the large intestine in the 6th week. Histologically, mucosal atrophy, small erosion, cellular infiltration with lymphocytes and plasma cells were seen remarkably in the ulcerative regions and cryptitis was also observed. PHA response was lowered gradually with the time compared with that before the administration of carrageenan in some cases and remained unchanged in other cases. We concluded that immunological mechanisms play and important role in formation of non-specific inflammatory lesion on the mucosa of experimental model, in addition to the direct action of carrageenan.
- 財団法人 日本消化器病学会の論文
著者
-
山本 祐夫
大阪市大第2内科
-
小林 絢三
大阪市大第3内科
-
片山 照義
大阪市大第3内科
-
北野 厚生
大阪市大第3内科
-
村井 雅巳
大阪市大第3内科
-
田中 吉之介
大阪市大第3内科
-
山口 勝治
大阪市大第3内科
-
桑島 士郎
大阪市大第3内科
関連論文
- 3. 微量全血培養法によるリンパ球ブラスト化の検討(6 細胞性免疫の試験管内テスト)
- 148 実験的急性肝不全の誘導に対するガラクトシダーゼ処理LPSの影響
- 肝疾患と免疫(IV-3 応用:臓器)
- 232. 肝特異抗原 (Meyer) による自己免疫(臓器アレルギー)
- 345.活性化マクロファージから分泌されるchemical mediatorによる肝細胞障害と血清因子による調節(肝炎)
- 344.活性化T-リンパ球から産生される催胆汁うっ滞因子の血清因子による影響(肝炎)
- 21 活性化マクロファージ培養上清中に含まれる肝細胞障害因子の部分精製(免疫担当細胞・マクロファージ)
- 50 リンホカインに含まれる催胆汁うっ滞因子による胆汁うっ滞に関する研究(Chemical mediatorsおよび類似物質)
- 25 各種肝疾患におけるK-cell populationへのmacrophage培養上清の影響(免疫担当細胞)
- 24 活性化マクロファージ培養上清に含まれる肝細胞障害因子について(免疫担当細胞)